Continue reading this on our app for a better experience
Open in App
Sign In
Subscribe
premium
latest
news
views
capital
digital edge
options
haven
videos
edgeinvest
events
Subscribe
Home
News
Company in the news
PREMIUM
Company in the news
SATS able to transport Pfizer’s experimental Covid-19 vaccine at low temperatures: CEO
Jeffrey Tan
Thu, Nov 12, 2020 • 08:04 PM GMT+08
•
• 1 min read
“We are certified to handle at that temperature,” says SATS CEO Alex Hungate.
Follow us on
Facebook
and join our
Telegram
channel for the latest updates.
TAGS
SATS
Pfizer
Covid-19 vaccine
Related News
Aviation & Engineering
SATS gives notice of three years of consecutive losses
by Felicia Tan
•
November 26, 2023
Company in the news
SATS establishes US$3 bil multicurrency debt issuance programme
by Felicia Tan
•
November 19, 2023
Broker's Calls
Brokers’ Digest: StarHub, Nanofilm, ST Engineering, FHT, Sats
by The Edge Singapore
•
November 19, 2023
Subscribe
Highlights
Investing strategies
US stock faithful ride US$7 trillion rally as market timing backfires
December 09, 2023
Trending Now
UOB Kay Hian stays 'overweight' on offshore and marine sector, favours Seatrium, Yangzijiang Shipbuilding and Marco Polo
Seatrium secures FPSO topside modules fabrication contract from MODEC
Is it time to add into S-REITs despite the sector's 7% gain in November?
OCBC's Wong reaffirms One Bank vision with eyes firmly on shareholders’ returns
Seatrium appoints Adrian Teng as new CFO
Related News
Aviation & Engineering
SATS gives notice of three years of consecutive losses
November 26, 2023
Company in the news
SATS establishes US$3 bil multicurrency debt issuance programme
November 19, 2023
Broker's Calls
Brokers’ Digest: StarHub, Nanofilm, ST Engineering, FHT, Sats
November 19, 2023
Subscribe
×
Loading next article...
Download The Edge Singapore App
Keep updated
Follow our social media
Subscribe to The Edge Singapore
Get credible investing ideas from our in-depth stock analysis, interviews with key executives, corporate movements coverage and their impact on the market.
Subscribe
Products & Services
News
Newsletter
Videos
Options
Edge Invest
Advertising
T&Cs
Sitemap
About Us
Our Company
Contact Us
Editorial Team
Join Us
FAQs
Privacy Policy
Malaysia
© 2023 The Edge Publishing Pte Ltd. All rights reserved.